Buket Yigit Civi

Buket Yigit Civi

Auto-generated profile, based on publicly available information

Buket Yigit Civi

Department of Obstetrics and Gynecology, University of Health Sciences, Kartal Lütfi Kırdar City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2026 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
İsmail Bağlarİsmail Bağlar
İsmail Bağlar
TTTamer Topaloglu
Tamer Topaloglu
EKESRA KELES
ESRA KELES
AYAylin Yılmaz
Aylin Yılmaz
SKSule Yildirim Kopuk
Sule Yildirim Kopuk
DADilanur Agir
Dilanur Agir

29 July 2026 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
İsmail Bağlarİsmail Bağlar
İsmail Bağlar
FŞFatih Şanlıkan
Fatih Şanlıkan
EKESRA KELES
ESRA KELES
BCBuket Yigit Civi
Buket Yigit Civi
AYAylin Yılmaz
Aylin Yılmaz
ASAslı Sasmaz
Aslı Sasmaz

1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
BKBeyzanur Kahyaoğlu
Beyzanur Kahyaoğlu
EKESRA KELES
ESRA KELES
İsmail Bağlarİsmail Bağlar
İsmail Bağlar
MGMehmet Güçlü
Mehmet Güçlü
BÇBuket Yiğit Çivi
Buket Yiğit Çivi
GDGizem Elif Dizdaroğulları
Gizem Elif Dizdaroğulları
OBJECTIVE: The aim of the study was to assess the predictive value of the triglyceride-glucose index and atherogenic indices for infertility in women with polycystic ovary syndrome.

10 June 2026 in Ege Tıp Dergisi
Verified
Journal Article
Closed access
İsmail Bağlarİsmail Bağlar
İsmail Bağlar
FŞFatih Şanlıkan
Fatih Şanlıkan
EKESRA KELES
ESRA KELES
BÇBuket Yiğit Çivi
Buket Yiğit Çivi
SGSevki Goksun Gokulu
Sevki Goksun Gokulu
BSBurak Sezgin
Burak Sezgin
Aim: Preeclampsia (PE) poses a significant threat to maternal and fetal health. The Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) index has emerged as a novel biomarker providing information on inflammation and nutritional status. The aim of this study is to evaluate the performance of the HALP index in diagnosing PE, comparing it with other commonly used inflammatory and nutritional markers.Materials and Methods: In this retrospective case-control study, 173 women who gave birth at a tertiary hospital between 2020 and 2025 and were diagnosed with PE were examined, along with a control group of 185 healthy pregnant women. The HALP score, Prognostic Nutritional Index (PNI), Neutrophil-Lymphocyte Ratio (NLR), Systemic Immune-Inflammation Index (SII), and serum uric acid/creatinine ratio (sUA/sCr) were calculated for the participants. Diagnostic performance was evaluated using ROC curves and comparing AUC (Area Under the Curve) values.Results: In women in the PE group, the HALP score (2.5 vs. 3.8) and PNI value (34.5 vs. 41.0) were significantly lower (p < 0.001 for both). In contrast, NLR, SII, serum uric acid level, and sUA/sCr ratio were significantly higher in the PE group (all p < 0.001). According to ROC analysis, uric acid had the highest diagnostic accuracy with an AUC value of 0.805 (95% CI: 0.758-0.852). The HALP score showed a significant but relatively low diagnostic accuracy (AUC: 0.625, 95% CI: 0.566-0.684),(p < 0.01 for all).Conclusions: Although the HALP score is significantly lower in women with preeclampsia, its diagnostic performance during diagnosis lags behind established biomarkers such as uric acid, sUA/sCr, PNI, and SII.